HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260)
South Korea · Delayed Price · Currency is KRW 3,980.00
+55.00 (1.40%)
At close: Sep 11, 2026
HYUNDAI BIOLAND Market Cap
HYUNDAI BIOLAND has a market cap or net worth of 119.4 billion as of September 11, 2026. Its market cap has decreased by -10.56% in one year.
Market Cap
119.40B
Enterprise Value
99.94B
Revenue
140.70B
Ranking
n/a
PE Ratio
8.95
Stock Price
3,980.00
ChartMarket Cap Chart
Since March 1, 2002, HYUNDAI BIOLAND's market cap has increased from 25.40B to 119.40B, an increase of 370.02%. That is a compound annual growth rate of 6.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 119.40B | -7.33% |
| Dec 30, 2025 | 128.85B | -4.87% |
| Dec 30, 2024 | 135.45B | -9.52% |
| Dec 28, 2023 | 149.70B | -25.80% |
| Dec 29, 2022 | 201.75B | -21.80% |
| Dec 30, 2021 | 258.00B | -29.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CellBion | 161.32B |
| Cosmax Nbt | 153.96B |
| Kyung Dong Pharmaceutical | 148.84B |
| PHARMARESEARCH BIO | 126.68B |
| Ahn-Gook Pharmaceutical | 115.47B |
| High Tech Pharm | 109.63B |
| OPTUS Pharmaceutical | 100.76B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 97.68B |